3SOF

Wow - I'm quite a trader, huh?



Currently I'm 14.53% underwater with my NTRZ that I bought on friday.

I guess I'll hang on to them - can't bear to sell with a loss.

Quote from: cumulina on September 04, 2007, 03:25:59 PM
Wow - I'm quite a trader, huh?



Currently I'm 14.53% underwater with my NTRZ that I bought on friday.

I guess I'll hang on to them - can't bear to sell with a loss.

Hmmm.... We have to work on the timing but it seems like the relentless selling has been replaced by relentless buying 

Nutracea is a great growth story even though it is still not reflected on the bottom line as the company has to take upfront cost to prepare for expansions.

Concerning arsenic this statement will hopefully put that issue to rest: http://www.nutracea.com/arsenic_announcement.php

Somebody made a killing below 1.2!

imho NTRZ will be going down once again, I will start to buy below 1.2$ 

cheers
Oliver

Press Release Source: NutraCea


NutraCea to Present at the ThinkEquity Partners' 5th Annual Growth Conference
Wednesday September 12, 8:00 am ET


PHOENIX, Sept. 12 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ - News), a leader in stabilized rice bran ("SRB") nutrient research and technology, announced today that Brad Edson, CEO, is scheduled to present at the ThinkEquity Partners' 5th Annual Growth Conference on Wednesday, September 19, 2007 at 7:30 am PDT. The conference is being held at the St. Regis Hotel in San Francisco, CA. A live Webcast of the presentation can be heard at: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=NTRZ&item_id=1634193 and will be archived for replay for a period of 90 days.


Mr. Edson commented, "I am pleased to be presenting the NutraCea story at this annual conference hosted by ThinkEquity Partners. We appreciate the invitation extended by ThinkEquity, which has an excellent reputation of focusing on emerging small cap situations, such as NutraCea."

About NutraCea

NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. Through its wholly owned subsidiary RiceX, the company manufacturers as well as distributes products and food ingredients made from Rice Bran through its proprietary technology and processes. The Company has developed intellectual properties to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health- promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the company's filings with the SEC and you can visit the NutraCea web site http://www.nutracea.com.

    Company Contact:           Investor Relations Contact:

    Margie Adelman             Stephen D. Axelrod, CFA
    Senior V.P. NutraCea       Wolfe Axelrod Weinberger Assoc, LLC
    916-933-7000 Ext. 646      212-370-4500
    916-220-3500 cell          [email protected]
    [email protected]

                               Media Relations Contact:
                               Alisa D. Steinberg
                               Wolfe Axelrod Weinberger Assoc, LLC
                               212-370-4500
                               [email protected]
--------------------------------------------------------------------------------
Source: NutraCea

bought some NTRZ today, looks like a breakout on some decent volume ...

NTRZ: Volume Spike; 20% > 20-adsv, Stock +12.68%
Wednesday, September 19, 2007 11:55ET

This is the 2nd VOLUME alert for NTRZ in the past 7 calendar days.

Trading for NutraCea (OTCBB: NTRZ) has been heavier than usual in today's session. By 11:55 ET, the stock had already traded 1,763,900 shares via 686 trades. The cumulative volume is 20.31% above its 20-day average of 1,466,105. Normally the stock experiences around 652 individual trades per session.

So far, today's volume surge has caused a net rise in NTRZ's stock price. At the time of this alert, the stock was trading at $1.600, up $0.180 (+12.68%).

One year ago, the Company's shares closed at $1.200. The price has gained more than 33 percent since then.

Over the last 10 trading session NTRZ has traded in a range between $1.150 and $1.660 and is currently trading 68.25% below its 52-week high of $5.040 set on May 15,2007 and 39.13% above its 52-week low of $1.150 from September 05,2007.

In the previous 3 sessions, NTRZ trading has displayed a mixed trend. Closing results have been as follows:

September 18, 2007 --- closed at $1.420 up $0.020 (+1.43%) on 916,200 shares
September 17, 2007 --- closed at $1.400 down $0.020 (-1.41%) on 1,615,100 shares
September 14, 2007 --- closed at $1.420 down $0.020 (-1.39%) on 662,400 shares

The Company has not released news in the past 30 days

NUTRACEA
The Company is a relatively new health science company focused on the development and distribution of products based upon the use of stabilized rice bran and proprietary rice bran formulations.

Nice run!

MA(50) might give us resistance and the stock seems to be a little overextended so I am taking profit here. I will hopefully be able to buy my shares back at a lower price 

Quote from: Michael on October 05, 2007, 10:40:30 AM
Nice run!

MA(50) might give us resistance and the stock seems to be a little overextended so I am taking profit here. I will hopefully be able to buy my shares back at a lower price 

you have your lower price here, seems grossly under valued, but at the same time in this bearish market there does not seem to be imminant news to lift it up.  Perhaps we will see .50 again on NTRZ, but i hope not!  Still appears to be a solid company... will see
cheers joe

was this the bottom?

higher without any news out

the saga continues..........

Press Release Source: NutraCea


NutraCea Announces 2007 Third Quarter and Nine Month Financial Results
Wednesday November 14, 5:30 pm ET


PHOENIX, Nov. 14 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ - News) a world leader in stabilized rice bran (SRB) nutrient research and technology announced today financial results for the third quarter and nine months ended September 30, 2007.


The Company reported consolidated net revenues of $1.5 million for the third quarter of 2007 compared to net revenues of $4.9 million for third quarter 2006, a decrease of $3.4 million. Gross product sales were reported at $3 million, excluding a product sales return of $1.5 million. The decrease is comprised of a $1.54 million increase in product sales, offset by a $4.4 million decrease in infomercial sales, including a $1.5 million sales return and a decrease of $490,000 in royalty revenues.

Net loss for the quarter was $(4. million, or $(0.03) per share, compared to net income of $641,000, or $0.01 per share for third quarter 2006.

Gross margins in the quarter ended September 30, 2007 were ($115,000), or (8%), compared to $2,411,000, or 49%, during the same period last year. Gross margins on our various product lines vary widely and the gross margins are impacted from period to period by sales mix and utilization of production capacity. The $2,526,000 decrease for the three months ended September 30, 2007 is comprised of the $803,000 decline corresponding to the decline in sales in the third quarter of 2007, a $1,284,000 decline associated with the return of product noted above, and a $490,000 decline in royalty and licensing fees.

Nine Month Results

Consolidated net revenues for the first nine months of 2007 were $16.5 million, compared to net revenues of $12.9 million for the first nine months of 2006, a $3.6 million increase. The revenue increase resulted from an $8.2 million increase in product sales, or 186% increase, offset by a decrease of $9.0 million in infomercial sales and a $1.5 million sales return in the third quarter, and a $4.5 million increase in royalty and licensing revenue.

The Company recorded a net loss of $3.0 million, or $(0.2) per share for the nine months ended September 30, 2007, compared to net income of $807,000, or $0.01 per share for the same period last year.

Gross margins in the nine months ended September 30, 2007 were $9,902,000, or 47%, compared to $5,396,000, or 44%, during the same period last year. Gross margins on our various product lines vary widely and the gross margins are impacted from period to period by sales mix and utilization of production capacity. The $3,976,000 increase for the nine months ended September 30, 2007 is comprised of the $755,000 increase corresponding to the sales growth in the nine months ended September 30, 2007, offset by the $1,284,000 decline associated with the return of product and a $4,504,000 increase in royalty and licensing fees.

Management will host the conference call on November 14 at 5:30 PM EST to review NutraCea's 2007 third quarter financial results and provide management updates. Parties interested in listening to the conference call should call 800-240-8926. International callers should dial 303-262-2143. The call is

also available via a webcast that can be accessed at http://www.vcall.com/IC/CEPage.asp?ID=123078 and will be archived for 30 days.

About NutraCea

NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. Through its wholly owned subsidiary RiceX, the company manufacturers as well as distributes products and food ingredients made from Rice Bran through its proprietary technology and processes. The Company has developed intellectual properties to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health- promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the company's filings with the SEC and you can visit the NutraCea web site http://www.nutracea.com.

Forward Looking Statements

In our conference call today, we may make forward-looking statements, including, but not limited to, statements regarding our future production capacity, revenue growth, international expansion, supply of raw rice bran, fluctuations in revenue and completion of facilities and transactions. Each of these statements are subject to market risks. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission, including the company's most recent periodic report.


     Company Contact:
     Margie Adelman
     Senior V.P. NutraCea
     602-522-3000
     916-220-3500 cell
     [email protected]

     Investor Relations Contact:
     Marilynn Meek
     Financial Relations Board
     212-827-3773
     [email protected]

     Julie Tu
     Financial Relations Board
     212-827-3776
     [email protected]
--------------------------------------------------------------------------------
Source: NutraCea

This Bullish Stampede Is Not Over.......
MACD is Bullish
Stochastic is Bullish
Support @ $1.45...1.21
Resistance @ $1.64...1.78

52wk Range: 0.01 - 5.04
Volume: 1,949,954
Avg Vol (3m): 1,618,230

Technicals
Last Price Quote is:
22.48%above 13-day MA
31.72%above 50-day MA
RS Rating: N/A 

Fundamentals
Key Data:
Market Cap (M): $189.89 
P/E Ratio: 32.82 
PEG Ratio: N/A 
Next Earnings: N/A
Last Analyst Rating: N/A

Starting to move again.......Volume picking up.
Health and Prices.
We must get more healthy, rice bran can assist.

52wk Range: 0.01 - 3.16
Volume: 5,329,975
Avg Vol (3m): 870,872

Technicals
Most Actives
Percentage Gainer

Last Price Quote is:
46.83%above 13-day MA
11.45%above 50-day MA
RS Rating: N/A 

Fundamentals
Earnings Expected on Aug 12

Key Data:
Market Cap (M): $77.98 
P/E Ratio: 32.82 
PEG Ratio: N/A 
Next Earnings: N/A
Last Analyst Rating: N/A

NTRZ - News

NutraCea Closes $10M Credit Facility Financing With Wells Fargo Bank


Technicals
Percentage Gainer

Last Price Quote is:
25.57%above 13-day MA
10.85%above 50-day MA
RS Rating: N/A 

Fundamentals
Key Data:
Market Cap (M): $60.52 
P/E Ratio: 32.82 
PEG Ratio: N/A 
Next Earnings: N/A
Last Analyst Rating: N/A


PHOENIX, Dec 18, 2008 /PRNewswire-FirstCall via COMTEX/ -- NutraCea (NTRZ, Trade), a world leader in stabilized rice bran (SRB), nutrient research and technology announced today it has closed a new credit facility with Wells Fargo Business Credit, a division of Wells Fargo Bank, N.A. The initial rate of interest varies from prime plus 2.5% to prime plus 3%.

NutraCea plans to use this facility to partially fund further expansion of certain projects that it currently has under construction and to enhance its ability to have additional liquidity available for the Company.

Olga Hernandez-Longan, Chief Financial Officer of NutraCea commented, "At a time when much of corporate America is finding access to traditional banking facilities extremely difficult, we are pleased to announce we have closed this new credit facility with Wells Fargo, further validating the financial strength of the Company and its prospects going forward. This facility will provide us with flexibility in financing our projects both here in the U.S. and Brazil and offers the Company additional liquid reserves as an alternative to issuing additional equity, as we continue to grow our business."

About NutraCea

NutraCea is a world leader in production and utilization of stabilized rice bran. They hold many patents for stabilized rice bran production technology and proprietary neutraceutical formulas ranging from arthritis, chronic bowel conditions, and effective diabetes control to cardiovascular disease treatment protocols. NutraCea's proprietary technology enables the creation of food and nutrition products to be unlocked from rice bran, normally a waste by-product of standard rice processing. Committed to helping the under fed, they're heavily involved in providing product and technology for developing countries through NutraCea's RiceAde feeding program. More information can be found in the Company's filings with the SEC and you can visit the NutraCea web site http://www.nutracea.com.

Forward Looking Statements

This release contains forward-looking statements, including statements regarding NutraCea's planned use of loan facility funds. Actual results may differ from those projected due to a number of risks and uncertainties, including, but not limited to the matters specified in the Company's filings with the Securities and Exchange Commission. These statements are made based upon current expectations that are subject to risk and uncertainty. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission, including the company's most recent periodic report.

SOURCE NutraCea



http://www.NutraCea.com 

Copyright (C) 2008 PR Newswire. All rights reserved